RAFAEL HOLDINGS, INC. Amortization
RAFAEL HOLDINGS, INC. (RFL) reported Amortization of $0 for the 9-month period ending 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2023-06-13
- RAFAEL HOLDINGS, INC. amortization for the quarter ending 2023-04-30 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. amortization for the quarter ending 2023-01-31 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. amortization for the quarter ending 2022-10-31 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. amortization for the quarter ending 2022-07-31 was $97.00K.
- RAFAEL HOLDINGS, INC. amortization for fiscal 2022 was $472.00K, a 1585.71% increase from fiscal 2021.
- RAFAEL HOLDINGS, INC. amortization for fiscal 2021 was $28.00K.
- RAFAEL HOLDINGS, INC. amortization for fiscal 2020 was $0.00.
| Period end | Amortization 3 month | Amortization 3 month as first filed | Amortization 6 month | Amortization 9 month | Amortization 12 month | Amortization 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $0.00 derived: sum of 2 quarters · filed 2023-06-13 | $0.00 10-Q · filed 2023-06-13 | $97.00K derived: sum of 4 quarters · filed 2023-06-13 | ||
| 2023-01-31 | $0.00 10-Q · filed 2023-06-13 | $0.00 10-Q · filed 2023-03-14 | $97.00K derived: sum of 3 quarters · filed 2023-06-13 | $222.00K derived: sum of 4 quarters · filed 2023-06-13 | ||
| 2022-10-31 | $0.00 10-Q · filed 2022-12-13 | $97.00K derived: sum of 2 quarters · filed 2022-12-13 | $222.00K derived: sum of 3 quarters · filed 2022-12-13 | $347.00K derived: sum of 4 quarters · filed 2023-06-13 | ||
| 2022-07-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $222.00K derived: sum of 2 quarters · filed 2022-10-31 | $347.00K derived: sum of 3 quarters · filed 2023-06-13 | $472.00K 10-K · filed 2022-10-31 | ||
| 2022-04-30 | $125.00K 10-Q · filed 2022-06-14 | $250.00K derived: sum of 2 quarters · filed 2023-06-13 | $375.00K 10-Q · filed 2023-06-13 | |||
| 2022-01-31 | $125.00K 10-Q · filed 2023-06-13 | $250.00K 10-Q · filed 2023-03-14 | ||||
| 2021-10-31 | $125.00K 10-Q · filed 2022-12-13 | $124.99K 10-Q · filed 2021-12-15 | ||||
| 2021-07-31 | $28.00K 10-K · filed 2022-10-31 | $27.78K 10-K · filed 2021-10-18 | ||||
| 2020-10-31 | $0.00 10-Q/A · filed 2022-02-28 | |||||
| 2020-07-31 | $0.00 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |